Physician profile
Laura Phan
NPI 1538366984
$1,258.99
in general payments reported to CMS, 2019-2025
17 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $94.31 · 2021: $159 · 2022: $269 · 2023: $94.85 · 2024: $349 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $584.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $297.22 | 2024-2025 | Tepezza |
| Abbvie INC. | $145.34 | 2024 | |
| Portola Pharmaceuticals, LLC | $129.68 | 2019 | |
| Novartis Pharmaceuticals Corporation | $97.38 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $96.61 | 2022 | |
| Oyster Point Pharma, INC. | $86.77 | 2022-2024 | Tyrvaya |
| Merz Pharmaceuticals, LLC | $73.97 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $63.94 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $52.99 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $40.83 | 2020 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Allergan, INC. | $37.28 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $24.26 | 2023 | Vyzulta |
| Kala Pharmaceuticals, INC. | $22.97 | 2022 | |
| Horizon Therapeutics Plc | $21.65 | 2023 | Tepezza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $17.64 | 2024 | |
| Galderma Laboratories, L.P. | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Phan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.